Open Culture
Open Culture (also known as Open Culture Science) is a Santa Cruz, California neuroscience instrumentation and software company spun out of UC Santa Cruz's Braingeneers group under an exclusive UC license.
About
Open Culture (also known as Open Culture Science) is a Santa Cruz, California neuroscience instrumentation and software company spun out of UC Santa Cruz's Braingeneers group under an exclusive UC license. It builds automated living-neuron and organoid culture and electrophysiology instruments (Habitat/Autoculture), a cloud Scientific Memory Commons for protocols and data, and real-time neuronal analysis and agentic electrophysiology tools for academic labs, core facilities and biopharma R&D.
Capital graph
Founders / team· 2
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Open Culture
Automated live-neuron culture and electrophysiology instruments + experimental data-sharing cloud + AI electrophysiology analysis tools…
—
United States
BusinessLatest roundTotal raisedDate- The Biological Computing Co.
Grows living neurons in vitro, stimulates them with real data and decodes their responses…
Seed · $50M · 2026-09
$50M - Portal Biotechnologies
Silicon micropore mechanical-poration intracellular delivery hardware (Gateway, Millibooster, Galaxy-i, etc.) and consumables for pharma companies…
$5M
$5M - Mira
Connected at-home hormone monitor, disposable test sticks, AI analysis app and online hormone health clinic for women trying to conceive…
$5M
$5M
China
BusinessLatest roundTotal raisedDateEurope
BusinessLatest roundTotal raisedDate- ScienceMachine
AI bioinformatics agents to automate experiments and data analysis
Pre-Seed · $4M · 2025-07
$4M - Silvia Bio
Biologics manufacturing process optimization: bioinformatics analysis + cell assay kits + licensable culture media additives
Seed · $4M · 2026-10
$4M - Vitroscope
Ex vivo perfusion culture systems for living human tissue (vitro.alive / vitro.scale) that generate longitudinal biological data for drug discovery
Seed · $9M · 2026-11
$9M
Other / unspecified
BusinessLatest roundTotal raisedDate- ChemT Biotechnology
CelMo AI virtual cell platform helping biopharma/CDMO companies improve cell culture and antibody production efficiency
Seed · $5M · 2026-06
$5M - Reliant AI
Uses generative AI to help biopharma companies organize and analyze data for clinical trials or scientific publications
Seed · $11M · 2024-08
$11M - Scispot
Lab operating system for biotech and pharmaceutical labs
Series A · $10M · 2026-06
$10M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Andreessen Horowitz
22 Life Sciences deals in the last 24 months · 20 in United States
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.